Formycon Gets Date For Aflibercept Filing In US

US FDA Offers June 2024 Action Date For Coherus-Partnered FYB203 Eylea Biosimilar

Eyes US flag
Formycon is eyeing a June 2024 FDA action date for FYB203 • Source: Shutterstock

More from Biosimilars

More from Products